JD Health International (6618) Stock Overview
An investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
6618 Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
JD Health International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$65.80 |
| 52 Week High | HK$70.40 |
| 52 Week Low | HK$25.70 |
| Beta | 1.16 |
| 1 Month Change | 3.05% |
| 3 Month Change | 58.55% |
| 1 Year Change | 90.17% |
| 3 Year Change | 40.00% |
| 5 Year Change | n/a |
| Change since IPO | -40.18% |
Recent News & Updates
Recent updates
Is Now The Time To Look At Buying JD Health International Inc. (HKG:6618)?
Sep 22
JD Health International Inc.'s (HKG:6618) Shareholders Might Be Looking For Exit
Aug 06JD Health International (HKG:6618) Could Be Struggling To Allocate Capital
Jul 07Is There Now An Opportunity In JD Health International Inc. (HKG:6618)?
Jun 22Is Now The Time To Put JD Health International (HKG:6618) On Your Watchlist?
May 22What JD Health International Inc.'s (HKG:6618) 37% Share Price Gain Is Not Telling You
May 07JD Health International (HKG:6618) Could Be Struggling To Allocate Capital
Mar 24
AI Integration With Jingyi Qianxun Will Improve Efficiency In Healthcare Services
Technological innovations and strategic partnerships aim to enhance customer experience, expand market share, and increase direct sales and margins.JD Health International Inc. Just Recorded A 32% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 09Calculating The Fair Value Of JD Health International Inc. (HKG:6618)
Feb 26Why Investors Shouldn't Be Surprised By JD Health International Inc.'s (HKG:6618) 27% Share Price Surge
Feb 10Should You Be Adding JD Health International (HKG:6618) To Your Watchlist Today?
Jan 24Should You Think About Buying JD Health International Inc. (HKG:6618) Now?
Jan 07JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business
Dec 17Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04Shareholder Returns
| 6618 | HK Consumer Retailing | HK Market | |
|---|---|---|---|
| 7D | 2.0% | 3.2% | 2.9% |
| 1Y | 90.2% | 35.3% | 20.7% |
Return vs Industry: 6618 exceeded the Hong Kong Consumer Retailing industry which returned 40.6% over the past year.
Return vs Market: 6618 exceeded the Hong Kong Market which returned 24.7% over the past year.
Price Volatility
| 6618 volatility | |
|---|---|
| 6618 Average Weekly Movement | 6.2% |
| Consumer Retailing Industry Average Movement | 7.8% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.8% |
| 10% least volatile stocks in HK Market | 3.4% |
Stable Share Price: 6618 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6618's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 4,572 | Enlin Jin | ir.jdhealth.com |
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions.
JD Health International Inc. Fundamentals Summary
| 6618 fundamental statistics | |
|---|---|
| Market cap | HK$210.66b |
| Earnings (TTM) | HK$5.16b |
| Revenue (TTM) | HK$71.16b |
Is 6618 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6618 income statement (TTM) | |
|---|---|
| Revenue | CN¥65.11b |
| Cost of Revenue | CN¥49.61b |
| Gross Profit | CN¥15.50b |
| Other Expenses | CN¥10.78b |
| Earnings | CN¥4.72b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.47 |
| Gross Margin | 23.81% |
| Net Profit Margin | 7.25% |
| Debt/Equity Ratio | 0% |
How did 6618 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 05:15 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
JD Health International Inc. is covered by 36 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiaomeng Zhuang | BofA Global Research |
| Shun Kei Law | CCB International Securities Limited |
| Hazim Bahari | CFRA Equity Research |